OUR TOOLS
Our close relationship with leading international universities and research institutes allows us to use the latest scientific tools, such as genetic polymorphisms, transcriptome, epigenetic analyses. We also use proteome analyses and laboratory analyses such as nitro stress and neurendocrine profiles. These are then reliably evaluated – in accordance with the strictest EBM measures (evidence based medicine).
All genetic markers are continuously chosen with the utmost care by a team of experts consisting of general practitioners and molecular biologists based on the published scientific evidence.
The content also includes biographical and lifestyle related data as well as the recording of genetic risks, which determine the risks associated with developing certain illnesses in different ways. All current calculating procedures (calculators) used by us to determine an individual risk originate from major, prospective studies carried out worldwide. They provide the opportunity of recognizing the development of an individual illness and to derive suitable preventative measures from it. This applies in particular to socalled widespread diseases such as cardiovascular and cerebrovascular diseases, malignoma, osteoporosis, diabetes mellitus Type 2 and dementia.